Ecstasy, one of the most popular and euphoric recreational drugs, has found an alternate use in treating post-traumatic stress disorder (PTSD) and the results are looking promising…
The U.S. Food and Drug Administration has officially designated MDMA (the pure form of ecstasy) as a “breakthrough therapy” for PTSD treatment. It’s a huge step in the decades-long effort to make “Molly” a prescription medication, rather than just a party buddy.
According to the Washington Post, the MDMA program researching and testing such drug therapy runs as a small group of psychedelic researchers. Currently, only two drugs are approved for treating PTSD — Zoloft and Paxil — and they hope to implement MDMA in addition or in replacement of these.
“If you were to design the perfect drug to treat PTSD, MDMA would be it,” said Rick Doblin, the founder of the California nonprofit behind these clinical trials.
Common festival drugs seem to be finding vital roles in modern day medical practices. LSD and mushrooms have also been explored. And, Ketamine, the “wonder drug,” was successful in its first clinical trial for treating elderly depression (study here).
Source: Washington Post